about
Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylationAcute consumption of a high-fat diet prior to ischemia-reperfusion results in cardioprotection through NF-κB-dependent regulation of autophagic pathways.Complementary, alternative, and putative nontroponin biomarkers of acute coronary syndrome: new resources for future risk assessment calculators.Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusionNF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning.Differential translocation of nuclear factor-kappaB in a cardiac muscle cell line under gravitational changes.The history and future of probenecid.Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.Reply to Christians: Hsf1 Knock-out.Synthesis and PGE2 inhibitory activity of novel diarylheptanoids.PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.Increased fibrosis and progression to heart failure in MRL mice following ischemia/reperfusion injury.Human antigen R as a therapeutic target in pathological cardiac hypertrophyAnti-inflammatory effects of HO-1 activity in vascular endothelial cells, commentary on "Carbon monoxide donors or heme oxygenase (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death"The stress-induced heat shock protein 70.3 expression is regulated by a dual-component mechanism involving alternative polyadenylation and HuRTranilast Blunts the Hypertrophic and Fibrotic Response to Increased Afterload Independent of Cardiomyocyte Transient Receptor Potential Vanilloid 2 ChannelsMechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis
P50
Q24635123-471E72AB-1EEE-4C3E-B6AC-9433637A786AQ33891401-388E4A3D-9730-4EB3-9F02-EF2354BBD0BFQ35158755-900BC66F-28BD-4518-AB7B-B7E31287365FQ35194984-BE0A1466-CB4F-4D01-A053-2901B08A6361Q36603095-2A1A84F0-F63B-45BF-BABA-CBF9D3E177A0Q36603283-D9A2FD47-2015-4D0D-8D33-A3D955EA2BCCQ36700810-37D05E6A-2C41-4794-B26A-CEF168201D15Q37936912-DD6577CD-742C-4E07-9378-21B773D57188Q42587654-901F3199-3FE3-4576-91D3-C4D8234DD829Q46014971-E2664C93-34F0-4813-9E28-2B1AB774ACAFQ49378881-4525EB0B-8D0D-4959-9DB6-F905F4A1A0ADQ52723151-8219491B-071E-4FD8-8B96-92B90FEF4EEBQ53033970-C8670C17-8ACA-4570-BE27-0D93D6F0BBA7Q64120235-4C1FDF06-86D4-40F3-8291-835E0FF97647Q79955384-D6D912B0-4830-420C-81CD-75AE91593B01Q86847063-C3198228-48E8-4C7C-942D-18B71DC0C82CQ88455884-64C0EA51-DB0B-47AE-8F50-28C481BC6A2DQ91504152-9365CD8C-EF8E-4EFE-84E6-55D898F2EC21
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Tranter
@ast
Michael Tranter
@en
Michael Tranter
@es
Michael Tranter
@nl
Michael Tranter
@sl
type
label
Michael Tranter
@ast
Michael Tranter
@en
Michael Tranter
@es
Michael Tranter
@nl
Michael Tranter
@sl
prefLabel
Michael Tranter
@ast
Michael Tranter
@en
Michael Tranter
@es
Michael Tranter
@nl
Michael Tranter
@sl
P106
P1153
23053093200
P21
P31
P496
0000-0002-0609-3717